During the past decade, Woodland Cancer Care Center conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 49 clinical trials were completed, i.e. on average, 75.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 43 clinical trials were completed. i.e. 430% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Woodland Cancer Care Center" #1 sponsor was "National Cancer Institute (NCI)" with 48 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "Gynecologic Oncology Group" with 5 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Woodland Cancer Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Woodland Cancer Care Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Breast Carcinoma" (5 trials), "Recurrent Ovarian Carcinoma" (5 trials) and "Stage IV Cutaneous Melanoma AJCC v6 and v7" (5 trials). Many other conditions were trialed in "Woodland Cancer Care Center" in a lesser frequency.

Most popular intervention types in "Woodland Cancer Care Center" are "Drug" (79 trials), "Other" (66 trials), "Biological" (41 trials), "Procedure" (19 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (39 trials), "Quality-of-Life Assessment" (25 trials), "Cisplatin" (12 trials), "Nivolumab" (12 trials) and "Carboplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Woodland Cancer Care Center" are 76 trials for "All" genders and 18 trials for "Female" genders.

Currently, there are NaN active trials in "Woodland Cancer Care Center". undefined are not yet recruiting, 15 are recruiting, 57 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Woodland Cancer Care Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Woodland Cancer Care Center, 1 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".